Global Short Bowel Syndrome (SBS) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 97

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Short Bowel Syndrome (SBS) Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Short Bowel Syndrome (SBS) Drugs industry chain, the market status of Hospitals (Glucagon-Like Peptide-2 (GLP-2), Growth Hormone), Clinics (Glucagon-Like Peptide-2 (GLP-2), Growth Hormone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Short Bowel Syndrome (SBS) Drugs.

Regionally, the report analyzes the Short Bowel Syndrome (SBS) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Short Bowel Syndrome (SBS) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Short Bowel Syndrome (SBS) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Short Bowel Syndrome (SBS) Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Glucagon-Like Peptide-2 (GLP-2), Growth Hormone).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Short Bowel Syndrome (SBS) Drugs market.

Regional Analysis: The report involves examining the Short Bowel Syndrome (SBS) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Short Bowel Syndrome (SBS) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Short Bowel Syndrome (SBS) Drugs:
Company Analysis: Report covers individual Short Bowel Syndrome (SBS) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Short Bowel Syndrome (SBS) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sale Channel (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Short Bowel Syndrome (SBS) Drugs. It assesses the current state, advancements, and potential future developments in Short Bowel Syndrome (SBS) Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Short Bowel Syndrome (SBS) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Short Bowel Syndrome (SBS) Drugs market is split by Type and by Sale Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sale Channel in terms of volume and value.

Market segment by Type
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other

Market segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies

Major players covered
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Short Bowel Syndrome (SBS) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Short Bowel Syndrome (SBS) Drugs, with price, sales, revenue and global market share of Short Bowel Syndrome (SBS) Drugs from 2019 to 2024.
Chapter 3, the Short Bowel Syndrome (SBS) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Short Bowel Syndrome (SBS) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and sale channel, with sales market share and growth rate by type, sale channel, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Short Bowel Syndrome (SBS) Drugs market forecast, by regions, type and sale channel, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome (SBS) Drugs.
Chapter 14 and 15, to describe Short Bowel Syndrome (SBS) Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Glucagon-Like Peptide-2 (GLP-2)
        1.3.3 Growth Hormone
        1.3.4 Glutamine
        1.3.5 Other
    1.4 Market Analysis by Sale Channel
        1.4.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Retail Pharmacies
    1.5 Global Short Bowel Syndrome (SBS) Drugs Market Size & Forecast
        1.5.1 Global Short Bowel Syndrome (SBS) Drugs Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity (2019-2030)
        1.5.3 Global Short Bowel Syndrome (SBS) Drugs Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Short Bowel Syndrome (SBS) Drugs Product and Services
        2.1.4 Merck Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck Recent Developments/Updates
    2.2 Takeda
        2.2.1 Takeda Details
        2.2.2 Takeda Major Business
        2.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Product and Services
        2.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Takeda Recent Developments/Updates
    2.3 Emmaus Medical
        2.3.1 Emmaus Medical Details
        2.3.2 Emmaus Medical Major Business
        2.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Services
        2.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Emmaus Medical Recent Developments/Updates
    2.4 Ardelyx
        2.4.1 Ardelyx Details
        2.4.2 Ardelyx Major Business
        2.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Services
        2.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Ardelyx Recent Developments/Updates
    2.5 Naia Pharmaceuticals
        2.5.1 Naia Pharmaceuticals Details
        2.5.2 Naia Pharmaceuticals Major Business
        2.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
        2.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Naia Pharmaceuticals Recent Developments/Updates
    2.6 Nutrinia
        2.6.1 Nutrinia Details
        2.6.2 Nutrinia Major Business
        2.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Services
        2.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Nutrinia Recent Developments/Updates
    2.7 OxThera
        2.7.1 OxThera Details
        2.7.2 OxThera Major Business
        2.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Product and Services
        2.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 OxThera Recent Developments/Updates
    2.8 Sancilio Pharmaceuticals
        2.8.1 Sancilio Pharmaceuticals Details
        2.8.2 Sancilio Pharmaceuticals Major Business
        2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
        2.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
    2.9 Zealand Pharma
        2.9.1 Zealand Pharma Details
        2.9.2 Zealand Pharma Major Business
        2.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Services
        2.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Zealand Pharma Recent Developments/Updates

3 Competitive Environment: Short Bowel Syndrome (SBS) Drugs by Manufacturer
    3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturer (2019-2024)
    3.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Short Bowel Syndrome (SBS) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2023
        3.4.2 Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2023
    3.5 Short Bowel Syndrome (SBS) Drugs Market: Overall Company Footprint Analysis
        3.5.1 Short Bowel Syndrome (SBS) Drugs Market: Region Footprint
        3.5.2 Short Bowel Syndrome (SBS) Drugs Market: Company Product Type Footprint
        3.5.3 Short Bowel Syndrome (SBS) Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region
        4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2019-2030)
        4.1.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2019-2030)
        4.1.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2019-2030)
    4.2 North America Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030)
    4.3 Europe Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030)
    4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030)
    4.5 South America Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030)
    4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    5.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2019-2030)
    5.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2019-2030)

6 Market Segment by Sale Channel
    6.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    6.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2019-2030)
    6.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2019-2030)

7 North America
    7.1 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    7.2 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    7.3 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country
        7.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2030)
        7.3.2 North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    8.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    8.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country
        8.3.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2030)
        8.3.2 Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    9.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region
        9.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    10.2 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    10.3 South America Short Bowel Syndrome (SBS) Drugs Market Size by Country
        10.3.1 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2030)
        10.3.2 South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2030)
    11.3 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country
        11.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Short Bowel Syndrome (SBS) Drugs Market Drivers
    12.2 Short Bowel Syndrome (SBS) Drugs Market Restraints
    12.3 Short Bowel Syndrome (SBS) Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Short Bowel Syndrome (SBS) Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Short Bowel Syndrome (SBS) Drugs
    13.3 Short Bowel Syndrome (SBS) Drugs Production Process
    13.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Short Bowel Syndrome (SBS) Drugs Typical Distributors
    14.3 Short Bowel Syndrome (SBS) Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel, (USD Million), 2019 & 2023 & 2030
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 6. Merck Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Merck Recent Developments/Updates
    Table 8. Takeda Basic Information, Manufacturing Base and Competitors
    Table 9. Takeda Major Business
    Table 10. Takeda Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 11. Takeda Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Takeda Recent Developments/Updates
    Table 13. Emmaus Medical Basic Information, Manufacturing Base and Competitors
    Table 14. Emmaus Medical Major Business
    Table 15. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 16. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Emmaus Medical Recent Developments/Updates
    Table 18. Ardelyx Basic Information, Manufacturing Base and Competitors
    Table 19. Ardelyx Major Business
    Table 20. Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 21. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Ardelyx Recent Developments/Updates
    Table 23. Naia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Naia Pharmaceuticals Major Business
    Table 25. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 26. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Naia Pharmaceuticals Recent Developments/Updates
    Table 28. Nutrinia Basic Information, Manufacturing Base and Competitors
    Table 29. Nutrinia Major Business
    Table 30. Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 31. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Nutrinia Recent Developments/Updates
    Table 33. OxThera Basic Information, Manufacturing Base and Competitors
    Table 34. OxThera Major Business
    Table 35. OxThera Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 36. OxThera Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. OxThera Recent Developments/Updates
    Table 38. Sancilio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 39. Sancilio Pharmaceuticals Major Business
    Table 40. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 41. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Sancilio Pharmaceuticals Recent Developments/Updates
    Table 43. Zealand Pharma Basic Information, Manufacturing Base and Competitors
    Table 44. Zealand Pharma Major Business
    Table 45. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Services
    Table 46. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Zealand Pharma Recent Developments/Updates
    Table 48. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
    Table 49. Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 51. Market Position of Manufacturers in Short Bowel Syndrome (SBS) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Short Bowel Syndrome (SBS) Drugs Production Site of Key Manufacturer
    Table 53. Short Bowel Syndrome (SBS) Drugs Market: Company Product Type Footprint
    Table 54. Short Bowel Syndrome (SBS) Drugs Market: Company Product Application Footprint
    Table 55. Short Bowel Syndrome (SBS) Drugs New Market Entrants and Barriers to Market Entry
    Table 56. Short Bowel Syndrome (SBS) Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 58. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 59. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2019-2024) & (USD/Pcs)
    Table 62. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2025-2030) & (USD/Pcs)
    Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 64. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 65. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2019-2024) & (USD/Pcs)
    Table 68. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2025-2030) & (USD/Pcs)
    Table 69. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 70. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 71. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2019-2024) & (USD Million)
    Table 72. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2025-2030) & (USD Million)
    Table 73. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2019-2024) & (USD/Pcs)
    Table 74. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2025-2030) & (USD/Pcs)
    Table 75. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 76. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 77. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 78. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 79. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 80. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 81. North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 84. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 85. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 86. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 87. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 88. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 89. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 92. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 93. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 94. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 95. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 96. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 97. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 100. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 101. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 102. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 103. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 104. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 105. South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 108. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 109. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2019-2024) & (K Pcs)
    Table 110. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2025-2030) & (K Pcs)
    Table 111. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 112. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 113. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Short Bowel Syndrome (SBS) Drugs Raw Material
    Table 116. Key Manufacturers of Short Bowel Syndrome (SBS) Drugs Raw Materials
    Table 117. Short Bowel Syndrome (SBS) Drugs Typical Distributors
    Table 118. Short Bowel Syndrome (SBS) Drugs Typical Customers
List of Figures
    Figure 1. Short Bowel Syndrome (SBS) Drugs Picture
    Figure 2. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Glucagon-Like Peptide-2 (GLP-2) Examples
    Figure 5. Growth Hormone Examples
    Figure 6. Glutamine Examples
    Figure 7. Other Examples
    Figure 8. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Sale Channel in 2023
    Figure 10. Hospitals Examples
    Figure 11. Clinics Examples
    Figure 12. Retail Pharmacies Examples
    Figure 13. Global Short Bowel Syndrome (SBS) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Short Bowel Syndrome (SBS) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity (2019-2030) & (K Pcs)
    Figure 16. Global Short Bowel Syndrome (SBS) Drugs Average Price (2019-2030) & (USD/Pcs)
    Figure 17. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Short Bowel Syndrome (SBS) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 32. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 33. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Sale Channel (2019-2030)
    Figure 34. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2019-2030) & (USD/Pcs)
    Figure 35. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 37. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 44. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 53. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 63. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2019-2030)
    Figure 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Short Bowel Syndrome (SBS) Drugs Market Drivers
    Figure 76. Short Bowel Syndrome (SBS) Drugs Market Restraints
    Figure 77. Short Bowel Syndrome (SBS) Drugs Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Short Bowel Syndrome (SBS) Drugs in 2023
    Figure 80. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
    Figure 81. Short Bowel Syndrome (SBS) Drugs Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Related Reports

Global Short Bowel Syndrome (SBS) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Short Bowel Syndrome (SBS) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Pharma & Healthcare

Product Tags

Short Bowel Syndrome (SBS) Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>